Effects of dihydropyridine calcium antagonists on rabbit renal Na,K-ATPase activity in vitro

Dihydropyridines are reported to have a stimulatory effect on vascular smooth muscle Na,K-ATPase activity in vitro. We studied the effects of the dihydropyridine calcium antagonists nimodipine, nitrendipine, nisoldipine, niludipine, nifedipine and felodipine (10(-5) M) on purified Na,K-ATPase isolated from rabbit kidney outer medulla. We were unable to detect an effect of the drugs on the enzyme activity, either under optimal or suboptimal substrate conditions. Likewise, Na,K-ATPase activity, partly inhibited by the addition of ouabain (10(-6) M), Ca2+ (10(-3) M) or arachidonic acid (4 x 10(-5) M), was not influenced by the dihydropyridines. The absence of a stimulatory effect of dihydropyridines on renal Na,K-ATPase is in agreement with the known diuretic and natriuretic effects of the drugs in normotensive and hypertensive men.     

Stimulation of cardiac sarcolemmal (Na+--K+) ATPase activity by phosphorylase kinase.

Following preincubation with phosphorylase kinase, ATPase activities of heart sarcolemmal membranes were increased: total ATPase from 9.38+/-0.65 to 15.25+/-0.90 and ouabain-sensitive (Na+--K+)ATPase from 1.67+/-0.17 to 3.12+/-0.33 micron moles Pi/mg protein/h (mean +/- S.E. of 3 experiments); (Ca2+)ATPase and (Mg2+--Ca2+)-ATPase activities were not significantly altered due to phosphorylase kinase. Under these conditions, phosphorylase kinase catalyzed phosphorylation of sarcolemmal membranes. The kinase-catalyzed phosphorylation of membranes was increased by Ca2+ ions: at pH 6.8, 30% increase in phosphorylation was observed whereas at pH 8.5, 267% increase was noted due to this action. These findings support the view that Ca2+-dependent phosphorylation of membranes regulates (Na+--K+)ATPase.     

Effects of nitric oxide synthesis inhibition on the Na,K-ATPase activity in the kidney.

The present study was aimed at investigating the role of endogenous nitric oxide (NO) in regulating Na,K-ATPase activity in the kidney. The expression of alpha-1 and beta-1 subunits; and the enzymatic activity of Na,K-ATPase were determined in the kidney of rats treated with an NO synthase inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME). Following the treatment with L-NAME in the drinking water for 4 weeks, Na,K-ATPase activity was increased while tissue nitrite/nitrate levels were decreased in the kidney. Supplementation with L-arginine prevented the L-NAME-induced changes. The expression of either alpha-1 or beta-1 subunit protein of Na,K-ATPase, assessed by Western blot analysis, was not affected by L-NAME-treatment. An acute in vitro treatment of the kidney with L-NAME also caused an increase of Na,K-ATPase activity; which was again prevented by cotreatment with L-arginine. On the contrary, treatment with sodium nitroprusside significantly decreased Na,K-ATPase activity. These results suggest that the endogenous NO plays a direct inhibitory role on Na,K-ATPase activity in the kidney.     

Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase

Inhibition of Na,K-ATPase by cardiac glycosides is at least partially antagonized by K+. The kinetics of the antagonism, however, appear complicated because K+ is capable of reducing both association and dissociation rate constants for the glycoside-enzyme interaction. In order to better understand the effect of K+, inhibition of partially purified Na,K-ATPase obtained from rat brain, guinea-pig heart and rat heart by ouabain, digoxin, digoxigenin, dihydrodigoxin and cassaine were compared in the presence of 1, 3 or 10 mM K+. Higher concentrations of K+ caused a parallel shift to the right in the concentration-inhibition curves for these compounds. For ouabain or digoxin, the extent of the shift was minimal with rat brain enzyme, intermediate with guinea-pig heart enzyme and more substantial with rat heart enzyme. For digoxigenin, dihydrodigoxin or cassaine, the extent of the shift was substantial in all enzyme preparations. These results could not be explained from either the affinity of the enzyme for the compound or its lipid solubility alone. The concentrations of these compounds required to cause a 50 percent inhibition of enzyme activity were markedly different with rat brain enzyme, but relatively similar with rat heart enzyme. The effects of K+, which depend on the source of the enzyme and chemical structures of the compounds, have to be considered in studies on comparative effects of various compounds on Na,K-ATPase, [3H]ouabain binding, sodium pumping and the force of myocardial contraction.     

Effects of local anaesthetics on the activity of the Na,K-ATPase of canine renal medulla.

The purpose of this study is to characterize the effects of local anaesthetics on Na,K-ATPase activity. The ATPase activity of Na, K-ATPase-enriched membranes from canine renal medulla was determined in the absence and in the presence of lidocaine, procaine, tetracaine, benzocaine, bupivacaine, prilocaine, and procainamide at 37 and 25 degrees C. All of these local anaesthetics, except benzocaine, inhibit the activity of the Na,K-ATPase of canine renal medulla at both 25 and 37 degrees C. Benzocaine inhibits Na,K-ATPase activity at 37 degrees C, but stimulates activity at 25 degrees C. The influence of lidocaine on stimulation of Na,K-ATPase activity by Na(+) and K(+) was investigated. Lidocaine increases the apparent K(0.5) of the Na,K-ATPase for both Na(+) and K(+) and decreases the V(max) values for both ions. IC(50) values for lidocaine increase with increasing concentrations of both Na(+) and K(+). The data indicate that lidocaine diminishes the affinity of the Na,K-ATPase for Na(+) and K(+) and that binding of Na(+) or K(+) decreases the potency of lidocaine as an inhibitor of the Na,K-ATPase. Lidocaine markedly decreases the affinity of the Na,K-ATPase for ouabain, but only slightly diminishes the maximum amount of ouabain bound. Unprotonated lidocaine is apparently a more potent inhibitor than is the protonated form.     

Effect of pyridine and quinoline N-oxides on microsomal Na,K-ATPase activity

Some heteroaromatic N-oxides of pyridine and quinoline derivatives at concentrations ranging from 10⁻⁴ to 10⁻¹⁰ mole/liter inhibit Na,K-ATPase activity in cattle brain microsomes stronger than does strophanthin K (a drug used for the treatment of cardiac insufficiency). A new Na,K-ATPase activator, 2-(2,4-dimethoxystyryl)quinoline-N-oxide), has been found, which is capable of acting at concentrations within 10⁻⁶–10⁻⁹ mole/liter. Since these compounds activate the enzyme in very low concentrations, they can probably be effective for the treatment of some disorders involving violation of the Na,K-ATPase function. __________ Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 7, pp. 3–4, July, 2006.     

Effects of moderate hypothermia on sarcolemmal Na(+)/H(+) exchanger activity and its inhibition by cariporide in cardiac ventricular myocytes.

1. Specific inhibitors of the sarcolemmal Na(+)/H(+) exchanger (NHE) such as cariporide are being evaluated for cardioprotective therapy during cardiac surgery. We determined the effects of moderate hypothermia (25 degrees C), as occurs during cardiac surgery, on (1) sarcolemmal NHE activity and (2) the NHE-inhibitory potency of cariporide, in isolated adult rat ventricular myocytes. 2. As the index of NHE activity, trans-sarcolemmal acid efflux rate (J(H)) was determined by microepifluorescence in single cells (n = 8 to 11 per group), during recovery from intracellular acidosis in bicarbonate-free conditions. 3. Initially, myocytes were subjected to two consecutive acid pulses; these both occurred at 37 degrees C in the normothermic control group but the second pulse was at 25 degrees C in the moderate hypothermia group. J(H) values obtained after the first pulse were superimposed in both groups, indicating comparable cell populations. However, after the second pulse, J(H) values in the moderate hypothermia group were approximately 50% of those in the normothermic control group over the pH(i) range 6.80 - 7.10. 4. Similar results were obtained in cells subjected to a single acid pulse at 37 or 25 degrees C, with J(H) values in the latter group measuring approximately 60% of those in the former over the pH(i) range 6.80-7.10. 5. Cariporide (0.01, 0.03, 0.1, 0.3, 1.0 or 3.0 microM), present during recovery from a single acid pulse, reduced J(H) in a concentration-dependent manner, with IC(50) values of 150 and 130 nM at 37 and 25 degrees C, respectively. 6. We conclude that moderate hypothermia produces (1) a significant, but partial, inhibition of sarcolemmal NHE activity, and (2) no significant effect on the NHE-inhibitory potency of cariporide.     

Inhibition of Na,K-ATPase activity and ouabain binding by sanguinarine

Sanguinarine, an isoquinoline alkaloid belonging to the benzophenanthridine class, has been found to be a time-dependent inhibitor of cardiac Na,K-ATPase activity. Enzyme inhibition depended on the concentration of enzyme in the assay. Dilution and centrifugation of the enzyme following incubation with sangunarine did not decrease inhibiton. Inhibiton of ouabain binding by sanguinarine was also time-dependent and resulted in a reduction of the equilibrium level of ouabian bound to the enzyme preparation. This suggests the possibility that the positive inotropic effect of sanguinarine on the heart may be due to interaction with the cardiac glycoside receptor site on Na,K-ATPase. Alternatively, sanguinarine may bind nonspecifically to phospholipids associated with the enzyme and exert its effects via conformational changes.     

维拉帕米和卡托普利对L－甲状腺素诱发的大鼠心肌肥厚及左心室质膜Na~＋，K~＋

ｐｏＬ－甲状腺素４ｍｇ·ｋｇ￣（－１）·ｄ￣（－１）×７ｄ诱发大鼠心肌肥厚及左心室质膜Ｎａ￣＋，Ｋ￣＋－ＡＴＰ酶活力升高（２．３３±０２７ｖｓ１．２０±０．１４ｍｍｏｌ·ｈ￣（－１）·ｇ￣（－１）蛋白），观察维拉帕米和卡托普利对此作用的影响，经维拉帕米５和１０ｍｇ·ｋｇ￣（－１）·ｄ￣（－１）以及卡托普利５ｍｇ·ｋｇ￣（－１）·ｄ￣（－１）治疗３ｄ后，显著降低大鼠心肌肥厚程度，但不能恢复至正常状态；仅维拉帕米１０ｍｇ·ｋｇ￣（－１）·ｄ￣（－１）组鼠左心室肥厚程度显著降低。两药物均能显著降低肥厚左心室质膜Ｎａ￣＋，Ｋ￣＋－ＡＴＰ酶活力，高剂量维拉帕米可使该酶活力恢复至正常水平，提示：维拉帕米和卡托普利可能通过下调Ｎａ￣＋，Ｋ￣＋－ＡＴＰ酶活力防止心肌ＡＴＰ耗竭和缺血损伤     

Frequency-dependent changes in the cardiac sarcolemmal ATPase.

1 Effects of various frequencies (0.25, 0.5, 1.0, 1.5 or 2.0 Hz) of stimulation for various durations (2, 5, 10 or 15 min) on the contractile force of trabecular or papillary muscles of dog myocardium were investigated. 2 Effects of various frequencies (0, 0.25, 0.5, 1.0, 2.0 Hz) of various stimulus strengths (0.5, 1, 10 V) for various durations (2,5,10 or 15 min) on the Mg2+/-dependent Na+/--K+/--adenosinetriphosinetriphosphatase (ATPase) of isolated sarcolemmal fraction of dog myocardium were determined. 3 There was a frequency-dependent increase in the contractility and inhibition of the Na+/--K+/--ATPase within 2 minutes. 4 Frequency-dependent increase in the contractility and inhibition of Na+/--K+/--ATPase decreased as the duration of stimulation was increased. 5 The diminution in the inhibition of ATPase was associated with a decrease in the contractility with prolonged stimulation. 6 These results suggest that the frequency-dependent increase in the myocardial contractility might be mediated through an inhibition of the sarcolemmal ATPase.     

A possible action of nicardipine on the cardiac sarcolemmal Na+-Ca2+ exchange

The effects of nicardipine on sodium-calcium exchange activity of cardiac sarcolemma-enriched vesicles isolated from the rat heart were examined. Sodium-loaded, sarcolemma-enriched vesicles, when exposed to a medium containing 40 microM CaCl2, exhibited about 5 nmoles Ca2+/mg protein of the maximal calcium uptake; the initial rate was 21 nmoles Ca2+/mg protein/min. The calcium uptake was dependent on the extravesicular concentration of calcium ion. Nicardipine at concentrations of 0.1 to 10 microM depressed the rate of calcium uptake activity by 60-90%. The isolated membrane vesicles preloaded with Ca2+ showed a calcium efflux activity, when exposed to a medium containing sodium ion. The rate of calcium efflux was 2.5 nmoles Ca2+/mg protein/min, when measured in a medium containing 6.5 mM NaCl. The efflux rate was facilitated with increased concentrations of sodium ion in the medium. About 75% of the preloaded calcium in the vesicles was released within 3 min of incubation. The rate of calcium efflux was stimulated in the presence of 0.1 to 10 microM nicardipine (2.5- to 4-fold increase). The present results suggest a possible action of nicardipine on the sodium-calcium exchange mechanism at cardiac sarcolemmal sites.     

低浓度毒毛旋花子苷元的强心作用及其与心肌细胞膜Na~＋，K~＋-ATP酶的关系

目的:观察低浓度的毒毛旋花子苷原(Strophanthidin,Str)对离体豚鼠心脏是否有强心作用,及其与心肌细胞膜Na~+,K~+-ATP酶活性的关系。方法:采用Langendorff离体灌流装置经主动脉逆行灌流心脏;八道生理记录仪记录心率(HR),左室内压(LVP)及其最大变化速率(±dP/dt_(max));无机磷法测定心肌细胞膜Na~+,K~+-ATP酶活性。结果:Str 0.1nmol/L可兴奋Na~+,K~+-ATP酶活性(P<0.05)但不影响心脏的收缩功能,Str 1nmol/L仅能升高+dP/dt_(max)(P<0.05)并兴奋Na~+,K~+-ATP酶活性(P<0.01),Str 10和100 nmol/L可升高LVP和+dP/dt_(max)(P<0.05或P<0.01),对Na~+,K~+-ATP酶活性无明显作用,Str 1-100μmol/L虽能短暂升高LVP和±dp/dt_(max)(P<0.01),但随后出现不规则收缩并使LVP和±dP/dt_(max)降低,其对Na~+,K~+-ATP酶活性则表现为剂量依赖性抑制作用(P<0.01)。结论:高浓度Str的正性肌力作用是通过抑制Na~+,K~+-ATP酶活性实现的,而低浓度Str的强心作用似与Na~+,K~+-ATP酶抑制作用无关。     

Influence of digoxin on the Na,K-ATPase activity,transmembrane potential,and contractile activity of ischemically damaged rat heart

Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 26, No. 6, pp. 12–15, June, 1992.     

Na,K-ATPase activity is selectively increased in thalamus in thiamine deficiency prior to the appearance of neurological symptoms

The relationship between progression of neurological status and the activities of both Na⁺,K⁺- and Mg²⁺-dependent-ATPase (adenosine 5′-triphosphate phosphohydrolase) was investigated in brain regions of pyrithiamine-induced thiamine deficient rats. Thalamic Na⁺,K⁺-ATPase activity was selectively increased by 200% (P < 0.01) prior to the appearance of symptoms of thiamine deficiency and normalized in symptomatic rats. This selective transitory activation precludes a mediation by brain soluble fraction Na⁺,K⁺-ATPase modifiers as does the unaltered distribution in regional high-affinity [³H]ouabain binding densities observed throughout the time-course used in these experiments. Na⁺,K⁺-ATPase maintains cellular ionic gradients and has been implicated in neurotransmitter uptake and release mechanisms. The fact that the increased thalamic Na⁺,K⁺-ATPase activity coincides with the early alterations in serotonin metabolism observed in similarly treated animals and the concomitantly early increase in glucose utilization previously observed in the thalamus of thiamine-deficient rats is discussed.     

Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase

After phosphorylation of electric eel Na,K-ATPase by Na+, Mg2+, and ATP was terminated by removing the unbound Mg2+, the phosphoenzyme was able to bind ouabain upon the addition of 2 mM ouabain under certain conditions. This binding was demonstrated by a 50% inhibition of ATPase after the removal of unbound ouabain by a Sephadex G-50 column (ouabain trapping method). At 4 degrees, this ouabain binding was observed on the K+- sensitive phosphoprotein (E2P) formed in the presence of 10 mM Na+ but was not observed on the ADP-sensitive phosphoprotein (E1P) formed in the presence of 1000 mM Na+. The increase in the dephosphorylation rate of E2P with various concentrations of K+ paralleled the decrease in inhibition by the addition of 2 mM ouabain after the termination of phosphorylation. In 50-200 mM Na+, the eel enzyme used here formed the E1P-rich phosphoprotein, but this phosphoprotein could bind with ouabain, even though the presence of ADP or oligomycin, which prevents the conversion of E1P to E2P, partially interfered with this ouabain binding. At 25 degrees, ouabain binding with E1P-rich phosphoprotein was observed in higher yield (up to 71%), but in each of these cases ADP or oligomycin strongly inhibited ouabain binding. Moreover, ouabain binding with E2P-rich phosphoprotein did not significantly change with temperature, but ouabain binding with E1P-rich phosphoprotein increased more than 6 times at temperatures from 4 degrees to 25 degrees. From these results, it can be concluded that E2P can bind with ouabain in the absence of free Mg2+ whereas E1P cannot, and that the interconversion between E1P and E2P can be stimulated with ouabain binding and accelerated with elevation of temperature. ADP- and K+ -insensitive phosphoprotein probably is only a minor intermediate for ouabain binding.     

Selective inhibition of K(+)-stimulation of Na,K-ATPase by bretylium.

1. The effects of bretylium were investigated on purified Na,K-ATPase from guinea-pig heart and on the Na/K pump in trout erythrocytes, with a view to further identifying the mechanism(s) associated with its antiarrhythmic effects. 2. Na,K-ATPase activity of the thiocyanate-dispersed enzyme was determined by the measurement of inorganic phosphate produced by ATP hydrolysis. 3. When the concentrations of each of the Na,K-ATPase activating components were varied in turn, bretylium (1-5 mmol l-1) exhibited competitive-type effects against K+ with a Ki of 1.4 mmol l-1 and noncompetitive-type effects against Na+, Mg2+ and ATP. 4. In K+ influx studies in trout erythrocytes with 86Rb+ used as the marker, the inhibition of total influx observed with bretylium (5 and 10 mmol l-1) was attributable to the bretylium cation selectively inhibiting the Na/K pump-mediated influx with the associated tosylate anion inhibiting Na/K cotransport. 5. The observed inhibition kinetics indicated that the bretylium cation (2-15 mmol l-1) competitively inhibited K+ stimulation of the Na/K pump at 6 and 1.25 mmol l-1 external K+ with a mean K1 of 2.3 mmol l-1. 6. The effects demonstrated on the functioning Na/K pump in erythrocytes confirmed the Na,K-ATPase findings, with bretylium selectively inhibiting K+ stimulation of the pump mechanism in both cases. 7. It is suggested that Na,K-ATPase inhibition may contribute to the antiarrhythmic and positive inotropic effects of bretylium with the cardiac accumulation of bretylium also possibly being a further important factor.     

Factors influencing the onset of ouabain inhibition of Na,K-ATPase from guinea-pig myocardium.

1. The onset of ouabain inhibition was quantified by analysis with an integrated rate equation from experiments in which the activity of Na,K-ATPase from guinea-pig myocardium had been altered with adenosine 5'-triphosphate (ATP, 0.3-9 mmoll-1) in the absence and presence of a detergent. 2. Under control conditions with increasing ouabain (0.1-100 mumoll-1) and ATP (0.3-1 mmoll-1) concentrations, inhibition developed faster. The acceleration by ouabain became less effective at saturating concentrations leading to a non-linear relationship between pseudo-first-order rate constants of inhibition and ouabain concentration. With a rise of ATP to 3 and 9 mmoll-1, i.e., near total Mg concentration (5 mmoll-1), inhibition was retarded presumably because the free concentrations of Mg and uncomplexed ATP changed. Varying the ATP concentration had little effect on ouabain potency at steady state; Hill coefficients were less than 1. 3. The detergent alamethicin (23 micrograms ml-1) neither interfered with Na,K-ATPase activity nor with inhibition at steady state but accelerated its onset. This supports a role for a lipid barrier in the development of inhibition. 4. While the reaction of low concentrations of ouabain with the receptors seemed to govern inhibition rate, with an increase in steroid concentration in the presence of alamethicin, ATP-dependent enzyme activity interfered with the onset of inhibition. The transition of the enzyme between ouabain-sensitive and ATP-hydrolytic conformations consequently causes the non-linear concentration-dependence of pseudo-first-order rate constants. As the Hill coefficient was less than 1, a reaction of ouabain with two receptors also could have contributed to the special concentration-dependence of inhibition rates.     

Inhibition of the Na,K-ATPase of canine renal medulla by several local anesthetics.

The ATPase activity of Na,K-ATPase-enriched membranes from canine renal medulla was determined in the absence of local anesthetic and in the presence of procaine, chloroprocaine, bupivacaine, mepivacaine, lidocaine, and two quaternary derivatives of lidocaine (QX-222 and QX-314) at 37( composite function)C. Chloroprocaine (IC(50)= 13 mM) had slightly greater potency than procaine (IC(50)= 17.7 mM). Bupivacaine (IC(50)= 6.7 mM) was more potent than its congener mepivacaine (IC(50)> 10 mM, the solubility limit). QX-222 (IC(50)> 600 mM) and QX-314 (IC(50)= 132 mM) had less potency than lidocaine (IC(50)= 30.4 mM). This study supports the interpretation that the uncharged forms of local anesthetics are much more potent inhibitors of Na,K-ATPase activity than the cationic forms.     

Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation

The ADP-sensitive and K+ -sensitive phosphorylated forms of Na,K-ATPase (E1P and E2P, respectively) are believed to be the main phosphorylated intermediates of Na,K-ATPase. In the presence of 100 mM Na+, E2P is the major component of the phosphorylated form in all native Na,K-ATPase preparations known, including the microsomes of shark rectal glands. However, the Na,K-ATPase-rich membrane fragments of the electric eel formed a different type of phosphoenzyme, of which 80% was dephosphorylated by both 2 mM K+ and 1 mM ADP within 1 sec at 4 degrees under the same conditions. In the presence of oligomycin (50 micrograms/ml), only the percentage of K+ -sensitive phosphoenzyme was reduced in the eel enzyme, but no such effects were observed in the shark enzyme. However, the eel enzyme produced E2P-rich phosphoenzyme in the presence of 10 mM Na+, as did the shark enzyme in the presence of 100 mM Na+, and the shark enzyme formed the E1P-rich phosphoenzyme in the presence of 500-700 mM Na+, as did the eel enzyme in the presence of 100 mM Na+. These results suggest that the eel enzyme has a much higher affinity for Na+ on the Na+ site controlling the E1P-E2P equilibrium than does the shark enzyme, but we have not been able to explain this difference. Since the phosphorylated forms of both enzymes became more sensitive to both ADP and K+ at 25 degrees, both the interconversion of E1P to E2P and the reverse reaction seem to be accelerated by an increase in temperature. Oligomycin inhibited this conversion of E1P to E2P at 25 degrees as at 4 degrees, but did not inhibit the reverse reaction. Therefore, we conclude that E1P was the predominant phosphorylated form of the eel enzyme under the above conditions, and that E1P was converted to E2P and then dephosphorylated by K+.